1. 49-72 of 188 « 1 2 3 4 5 6 7 8 »
    1. Dow-DuPont: Activist Investors Pulling The Strings

      Dow-DuPont: Activist Investors Pulling The Strings

      There is the promise of marked upside if Dow and DuPont change their breakup strategy. Activist investors have been pulling the strings for years on this. But it could be time for Dow and DuPont that stand their ground. There’s been fresh activist investor pressure from Dan Loeb’s Third Point on Dow ( DOW ) and DuPont ( DD ), hoping to get the two to review post-merger plans. The companies recently hired McKinsey to review its post-merger spinoff situation...

      Read Full Article
    2. Procter & Gamble: Ready For A Real Rumble

      Procter & Gamble: Ready For A Real Rumble

      Activist investor Nelson Peltz and his Trian Partners has got a win at General Electric (NYSE: GE ), and now might be ready to take on its largest investment ever - Procter & Gamble (NYSE: PG ). Trian owns a $3.3 billion stake in P&G, while its GE stake is about $2 billion. The P&G stake is the biggest position in any company that Trian has ever taken...

      Read Full Article
    3. AT&T: Time Warner Deal Counter-Intuitively Lowers Risk For Current Shareholders

      AT&T: Time Warner Deal Counter-Intuitively Lowers Risk For Current Shareholders

      At first glance the massive debt load AT&T (NYSE: T) is set to inherent via the Time Warner (NYSE: TWX) acquisition is scary. It conjures up images of Atlas taking the entire weight of the world on his shoulders for me. Many extremely bearish articles and analyst notes regarding the massive debt load created by the AT&T and Time Warner merger have been published as of late...

      Read Full Article
    4. Chipotle: Bill Ackman Ready To Checkout

      Chipotle: Bill Ackman Ready To Checkout

      Will CMG be the next VRX for Bill Ackman? Ackman’s Pershing Square hedge fund has already positioned itself to dump its CMG stake. However, CMG is finally showing signs of life. Chipotle (NYSE: CMG ) is now one of the major focuses of activist investor Bill Ackman after Pershing Square dumped its Valeant Pharmaceuticals (NYSE: VRX ) stake. Ackman showed he has the patience to wait out a turnaround, as exhibited with VRX. However, Ackman is cleaning up his portfolio.

      Read Full Article
    5. At $55, DineEquity Is Ripe For An Activist Hedge Fund To Wade In

      At $55, DineEquity Is Ripe For An Activist Hedge Fund To Wade In

      At $55, DineEquity Is Ripe For An Activist Hedge Fund To Wade In Apr.17.17 Long/short equity, bonds, special situations, growth at reasonable price Summary I write to recommend a long position in shares of DineEquity at $54.59. I would argue its valuation is too cheap, and an activist hedge fund, eventually, will notice, as its IHOP franchise is a phenomenal business...

      Read Full Article
    6. Macy's: Starboard's Trash Can Be Your Treasure

      Macy's: Starboard's Trash Can Be Your Treasure

      Activist Starboard Value exits their position in Macy's. The stock has fallen significantly over the last 2 years. But if you haven't been along for the ride, and if you haven't considered the thesis, "it's new to you". One man's trash is another's treasure. We still like Macy's. By Parke Shall Activist investor Starboard Value exited their position in Macy's (NYSE: M ) late last week...

      Read Full Article
    7. Chipotle: Another Ackman Failure?

      Chipotle: Another Ackman Failure?

      Activist investor Bill Ackman has been little help for CMG. Instead, CMG needs to be its own activist with marketing spend and food safety investments. Ackman has board seats but no apparent long-term plan. Chipotle (NYSE: CMG ) is still too cheap. Or is it? The stock is down almost 50% from its 2015 high. And instead of hitting $1,000 a share as many analysts expected, we're now closer to $100. The fast casual restaurant can't seem to "recover" from the 2015 e-coli outbreak...

      Read Full Article
    8. Procter & Gamble: An Activist Investor Takes A Stake, But We Say Wait To Buy

      Procter & Gamble: An Activist Investor Takes A Stake, But We Say Wait To Buy

      Procter & Gamble has been undergoing a transformation program whereby it divested many of its non-core, less profitable brands to focus on its dominant, most profitable brands. Just as the company approaches the end of transformative activities, an activist investor emerges to exert additional pressure on it. Cost reduction efforts, however, continue.

      Read Full Article
    9. Corporate Earnings Season May Be Winding down, But...

      Corporate Earnings Season May Be Winding down, But...

      Corporate earnings season may be winding down, but the real earnings season—annual 10-K filing season—starts today. Successful value investors such as Warren Buffett know that it’s essential to read 10-Ks. It's the only way to reverse accounting distortions and calculate true return on invested capital (ROIC). The combination of computerized processing power and human expertise allows us to provide investors with the most accurate research from the “real” earnings season...

      Read Full Article
    10. CSX: Fighting A Losing Battle

      CSX: Fighting A Losing Battle

      Summary CSX is battling back against Bill Ackman protege Paul Hilal. The rail company has bought itself some additional time - calling a special meeting to allow shareholders to vote on the activist’s proposal. The likely path is that CSX "goes around" the activist to bring in rail expert Hunter Harrison. CSX (NYSE: CSX ) is pushing back at activist investor Paul Hilal's Mantle Ridge, which owns 4.9% of the railroad company...

      Read Full Article
    11. Floor & Decor has again filed its intention to go public

      Floor & Decor has again filed its intention to go public

      Floor & Decor has again filed its intention to go public, intending to raise $150 million in an IPO. The company is growing rapidly while managing its financial performance well. Management sees a 400 store market opportunity vs. its current 71 store footprint. I like the company's prospects and will provide an update when we know more about its IPO valuation expectations...

      Read Full Article
    12. The Battle For Bristol-Myers Begins

      The Battle For Bristol-Myers Begins

      BMY has fallen on hard times of late, one of the weakest performers in healthcare. However, activist JANA Partners is quietly lurking. What will be the catalyst for JANA to finally get more involved? Bristol-Myers (NYSE: BMY ) has activist investor Barry Rosenstein and his JANA Partners as a shareholder. JANA hasn't announced any plans, or even considered the stake activist. Still, JANA could be playing wait-and-see...

      Read Full Article
      Mentions: stock options
    13. Johnson & Johnson: Too Big To Break Up

      Johnson & Johnson: Too Big To Break Up

      Johnson & Johnson is at a $317 billion market cap. Which means it might be too big to grow, having underperformed for years. The only question is will a major activist step up or will JNJ become its own activist? It appears that it wil take a major activist to shake things up at the $300 billion-plus market cap healthcare giant Johnson & Johnson (NYSE: JNJ ).

      Read Full Article
    14. Twitter: New CEO, Finally?

      Twitter: New CEO, Finally?

      If high levels of insider selling is bad, what about high levels of insider resigning? Jack Dorsey continues to consolidate his power as CEO to run Twitter as a glorified chatroom. Twitter needs a new CEO, otherwise it’s a $12 stock. Again, Twitter (NYSE: TWTR ) needs a new CEO. As I've noted , ideally, Jack steps down (or gets fired - more likely) from TWTR in 2017 and runs Square (NYSE: SQ ) full-time. By all accounts, there's no buyout coming. But who can oust Jack Dorsey?

      Read Full Article
    15. Yahoo And Verizon: Either Way, It's Yahoo Shareholders That Lose

      Yahoo And Verizon: Either Way, It's Yahoo Shareholders That Lose

      Yahoo and Verizon continue to jockey for position with one another after the latest data breach revelations. Sell side analysts seem to think the deal will go through, but at a lower price. We're slightly more skeptical. No matter what the outcome, Yahoo shareholders remain the losers and this entire ordeal is a great reminder of why not to own Yahoo stock now, or going forward...

      Read Full Article
    16. Goldman Sachs Has A Lot Of Worries In 2017

      Goldman Sachs Has A Lot Of Worries In 2017

      President-elect Donald Trump's promised rollback of stiffer banking-industry rules implemented after the financial crisis eight years ago could easily get bogged down in regulatory agencies or Congress. European officials may erect competitive barriers that might protect the region's weakened banks from market-share intrusions by U.S. investment banks...

      Read Full Article
      Mentions: Dodd-Frank
    17. Wells Fargo & Co. - It Will Take A While To Restore

      Wells Fargo & Co. - It Will Take A While To Restore

      The pace of new consumer checking account openings continued to weaken since the company's September 8th announcement with October account openings down 27% from September and down 44% year-over-year. Balances remain fairly flat across deposit accounts (period end deposits for consumer and small business customers down 1% month-to-month but up 7% YoY) and existing customers...

      Read Full Article
    18. Don't Believe The Hype: Why It Makes No Sense For Buffett To Buy This Food Giant

      Don't Believe The Hype: Why It Makes No Sense For Buffett To Buy This Food Giant

      With Berkshire Hathaway sitting on $85 billion in cash the street is abuzz over rumors of the Oracle of Omaha's next big acquisition. Currently, investors are betting that Mondelez is the takeover target of Kraft Heinz. However, when while such a deal might make sense from a superficial level, when you actually look at the math, it just doesn't make sense...

      Read Full Article
    19. Praxair, Linde close in on deal

      Praxair, Linde close in on deal

      Praxair, Linde close in on deal Dec. 19, 2016 3:29 AM ET | About: Linde AG ADR (LNEGY) | By: Yoel Minkoff , SA News Editor According to various media reports, an agreement on their $65B merger could be announced as early as Wednesday. Initial discussions collapsed in September due to disputes over personnel, headquarters and other details, but Linde ( OTCPK:LNEGY ) is said to have revived talks after Praxair (NYSE: PX ) provided new assurances over jobs and corporate governance.

      Read Full Article
    49-72 of 188 « 1 2 3 4 5 6 7 8 »
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content